Comparative analysis of Nε-carboxymethyl-lysine and inflammatory markers in diabetic and non-diabetic coronary artery disease patients

doi:10.4239/wjd.v14.i12.1754

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 12

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1407)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-6) series.

Item

Count

PDF

WORD

HTML

808

Figures (1-2)

Tables (1-6)

106

Sum=1072

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

158

Sum=237

Dec 15, 2023 (publication date) through May 20, 2024

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Control Study

World J Diabetes. Dec 15, 2023; 14(12): 1754-1765
Published online Dec 15, 2023. doi: 10.4239/wjd.v14.i12.1754

Table 3 Biochemical parameters in diabetic coronary artery disease patients and non-diabetic coronary artery disease patients

Biochemical parameters	Group I, median (25%-75% quartile)	Group II, median (25%-75% quartile)	P value¹
Total cholesterol in mg/dL	143.50 (118.00-183.50)	132.00 (100.25-163.75)	0.006²
Triglycerides in mg/dL	150.00 (106.25-214.00)	114.00 (75.00-148.75)	0.001²
HDL-C in mg/dL	33.40 (27.33-38.98)	34.55 (28.70-41.00)	0.449²
LDL-C in mg/dL	78.00 (53.50-108.80)	73.00 (52.00-92.75)	0.278²
VLDL-C in mg/dL	29.00 (20.85-42.00)	23.00 (15.00-30.00)	0.001²
Random blood sugar in mg/dL	213.00 (131.50-275.75)	113.00 (99.00-135.00)	0.001²
HbA1c as %	8.09 (7.10-10.20)	5.70 (5.40-5.98)	0.001²
Urea in mg/dL	29.00 (23.00-39.60)	28.55 (24.85-34.00)	0.177²
Creatinine in mg/dL	0.90 (0.80-1.20)	1.00 (0.80-1.10)	0.811²
Total bilirubin in mg/dL	0.40 (0.30-0.70)	0.50 (0.40-0.69)	0.260²
Total protein in gm/dL	7.10 (6.80-7.60)	7.10 (6.73-7.48)	0.441²
Albumin in gm/dL	4.20 (4.00-4.40)	4.28 (4.00-4.50)	0.281²
ALP in U/L	108 (87.00-133.00)	95.50 (84.25-110.00)	0.054²
SGOT in U/L	26 (21.00-45.00)	30.00 (22.00-47.50)	0.240²
SGPT in U/L	28 (20.00-43.00)	29.95 (22.00-49.00)	0.187²
Sodium in mEq/L	136.00 (134.00-139.00)	139.00 (136.00-141.00)	0.001²
Potassium in mEq/L	4.60 (4.30-4.90)	4.35 (4.10-4.80)	0.002²
CML in ng/mL	264.43 (193.19- 364.34)	250.68 (195.95-333.70)	0.031²
IL-6 in pg/mL	2.75 (1.36-5.50)	2.36 (1.23-3.60)	0.011²
TNF-α in pg/mL	20.2 (13.65-25.32)	15.67 (11.137-21.785)	0.006²
Nitric oxide in nmol/mL	87.09 (59.84-124.37)	110.86 (77.00-150.00)	0.002²

¹P value < 0.05 is considered significant.

²Mann Whitney U test.

Group I: Diabetic coronary artery disease patients; Group II: Non-diabetic coronary artery disease patients. ALP: Alkaline phosphatase; CML: Nε-carboxymethyl-lysine; HbA1c: Glycosylated hemoglobin; HDL-C: High-density lipoprotein cholesterol; IL-6: Interleukin-6; LDL-C: Low-density lipoprotein cholesterol; SGOT: Glutamic-oxalacetic transaminase; SGPT: Glutamic-pyruvic transaminase; TNF-α: Tumor necrosis factor-alpha; VLDL-C: Very low-density lipoprotein cholesterol.

Citation: Shrivastav D, Singh DD, Mir R, Mehra P, Mehta V, Dabla PK. Comparative analysis of Nε-carboxymethyl-lysine and inflammatory markers in diabetic and non-diabetic coronary artery disease patients. World J Diabetes 2023; 14(12): 1754-1765
URL: https://www.wjgnet.com/1948-9358/full/v14/i12/1754.htm
DOI: https://dx.doi.org/10.4239/wjd.v14.i12.1754